Timber Pharmaceuticals, Inc.
AMEX:TMBR
1.4609 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.083 | 0.296 | 0.454 | 0.325 | 0.057 | 0.073 | 0.1 | 0.064 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 13.302 | 6.15 | 1.501 | 3.383 | 0.083 | 0.25 | 0.516 | 0.237 | 0 | 0 | 0 | 0 |
| Gross Profit
| -13.219 | -5.854 | -1.047 | -3.058 | -0.026 | -0.177 | -0.416 | -0.173 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -158.924 | -19.794 | -2.308 | -9.42 | -0.456 | -2.425 | -4.16 | -2.703 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 13.302 | 6.15 | 15.104 | 3.383 | 9.079 | 9.14 | 10.158 | 5.702 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 5.244 | 5.144 | 4.654 | 4.174 | 0 | 0.052 | 0.028 | 0.059 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 2.157 | 2.415 | 3.198 | 5.109 | 0 | 0 | 0 | 0 |
| SG&A
| 6.017 | 5.387 | 4.06 | 0.587 | 7.401 | 7.559 | 7.852 | 9.283 | 0 | 0.052 | 0.028 | 0.059 |
| Other Expenses
| -0.083 | -0.591 | -0.454 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 19.235 | 10.946 | 18.711 | 0.587 | 16.48 | 16.699 | 18.01 | 14.985 | 0 | 0.052 | 0.028 | 0.059 |
| Operating Income
| -19.235 | -10.65 | -20.212 | -3.645 | -17.228 | -23.936 | -18.241 | -15.594 | 0 | -0.052 | -0.028 | -0.059 |
| Operating Income Ratio
| -231.259 | -36.012 | -44.538 | -11.226 | -302.246 | -327.89 | -182.41 | -243.656 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.136 | -0.019 | 5.132 | -0 | -0.75 | 0.238 | -0.163 | -0.436 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -19.372 | -10.669 | -15.08 | -3.645 | -17.256 | -16.638 | -18.404 | -15.594 | 0 | -0.052 | -0.028 | -0.059 |
| Income Before Tax Ratio
| -232.899 | -36.077 | -33.229 | -11.227 | -302.737 | -227.918 | -184.04 | -243.656 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.008 | -0.03 | 0.038 | -0 | 0.002 | -7.66 | 0.002 | 0.004 | 0 | 0 | 0 | 0 |
| Net Income
| -19.379 | -10.639 | -15.118 | -3.69 | -17.258 | -8.978 | -18.406 | -15.598 | 0 | -0.052 | -0.028 | -0.059 |
| Net Income Ratio
| -232.99 | -35.975 | -33.313 | -11.367 | -302.772 | -122.986 | -184.06 | -243.719 | 0 | 0 | 0 | 0 |
| EPS
| -9.19 | -13.15 | -48.15 | -29.31 | -1,340.11 | -1,567.94 | -7,710.93 | -13,030.91 | 0 | -0.006 | -0.003 | -0.007 |
| EPS Diluted
| -9.19 | -13.15 | -48.15 | -29.31 | -1,340.11 | -1,567.94 | -7,710.93 | -13,030.91 | 0 | -0.006 | -0.003 | -0.007 |
| EBITDA
| -19.158 | -10.65 | -17.777 | -0.046 | -17.166 | -23.884 | -17.981 | -15.508 | 0 | -0.052 | -0.028 | -0.059 |
| EBITDA Ratio
| -230.328 | -36.012 | -39.173 | -0.14 | -301.158 | -327.178 | -179.81 | -242.313 | 0 | 0 | 0 | 0 |